All Stories

  1. Impact of blood component transfusions, tranexamic acid and fluids on subarachnoid hemorrhage outcomes
  2. Effects of Sound Interventions on the Permeability of the Blood–Brain Barrier and Meningeal Lymphatic Clearance
  3. Role of CRF and the hypothalamic‐pituitary‐adrenal axis in stroke: revisiting temporal considerations and targeting a new generation of therapeutics
  4. Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients
  5. Genome-Wide Association Study of Clinical Outcome After Aneurysmal Subarachnoid Haemorrhage: Protocol
  6. Potential Role of Soluble Toll-like Receptors 2 and 4 as Therapeutic Agents in Stroke and Brain Hemorrhage
  7. Cerebral Venous Thrombosis and Hypercoagulability Associated With In Vitro Fertilization
  8. Association of Serum Bilirubin with the Severity and Outcomes of Intracerebral Hemorrhages
  9. Carbon Monoxide Therapy Using Hybrid Carbon Monoxide-Releasing/Nrf2-Inducing Molecules through a Neuroprotective Lens
  10. Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease
  11. Nrf2 as a therapeutic target in ischemic stroke
  12. Haptoglobin Genotype Affects Inflammation after Aneurysmal Subarachnoid Hemorrhage
  13. Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools
  14. Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer’s Disease Mouse Models
  15. Distinctive effect of anesthetics on the effect of limb remote ischemic postconditioning following ischemic stroke
  16. Role of the PGE 2 receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury
  17. Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection
  18. Reactive Gliosis Contributes to Nrf2-Dependent Neuroprotection by Pretreatment with Dimethyl Fumarate or Korean Red Ginseng Against Hypoxic-Ischemia: Focus on Hippocampal Injury
  19. Nrf2 Plays an Essential Role in Long-Term Brain Damage and Neuroprotection of Korean Red Ginseng in a Permanent Cerebral Ischemia Model
  20. Haptoglobin genotype and aneurysmal subarachnoid hemorrhage
  21. Pretreatment with Korean red ginseng or dimethyl fumarate attenuates reactive gliosis and confers sustained neuroprotection against cerebral hypoxic-ischemic damage by an Nrf2-dependent mechanism
  22. Bilirubin and Ischemic Stroke: Rendering the Current Paradigm to Better Understand the Protective Effects of Bilirubin
  23. Unique Properties Associated with the Brain Penetrant Iron Chelator HBED Reveal Remarkable Beneficial Effects after Brain Trauma
  24. Genetic Deletion of PGF2α-FP Receptor Exacerbates Brain Injury Following Experimental Intracerebral Hemorrhage
  25. Haemoglobin scavenging in intracranial bleeding: biology and clinical implications
  26. A Pilot Study of Inhaled CO Therapy in Neonatal Hypoxia-Ischemia: Carboxyhemoglobin Concentrations and Brain Volumes
  27. Korean Red Ginseng Pretreatment Protects Against Long-Term Sensorimotor Deficits After Ischemic Stroke Likely Through Nrf2
  28. A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage
  29. Local Delivery Is Critical for Monocyte Chemotactic Protein-1 Mediated Site-Specific Murine Aneurysm Healing
  30. Limb Remote Ischemic Conditioning: Mechanisms, Anesthetics, and the Potential for Expanding Therapeutic Options
  31. Efficacy of Laropiprant in Minimizing Brain Injury Following Experimental Intracerebral Hemorrhage
  32. Role of Interleukin-10 in Acute Brain Injuries
  33. The absence of the CD163 receptor has distinct temporal influences on intracerebral hemorrhage outcomes
  34. Age-Dependent Effects of Haptoglobin Deletion in Neurobehavioral and Anatomical Outcomes Following Traumatic Brain Injury
  35. PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice
  36. Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage
  37. Increased brain hemopexin levels improve outcomes after intracerebral hemorrhage
  38. Animal Models of Posttraumatic Seizures and Epilepsy
  39. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke
  40. Considerations for the Optimization of Induced White Matter Injury Preclinical Models
  41. Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor
  42. Neuroprotective effert of carbon monoxide and Nrf2 in cerebral ischemia
  43. Genetic deletion of the prostaglandin E2E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage
  44. Prostaglandin E2 EP2 Receptor Deletion Attenuates Intracerebral Hemorrhage-Induced Brain Injury and Improves Functional Recovery
  45. Efficacy of prophylactic flavan-3-ol in permanent focal ischemia in 12-mo-old mice
  46. Ginseng: a promising neuroprotective strategy in stroke
  47. Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage
  48. Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity
  49. Role of the Prostaglandin E2 EP1 Receptor in Traumatic Brain Injury
  50. Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism
  51. Heme–Hemopexin Complex Attenuates Neuronal Cell Death and Stroke Damage
  52. The Flavanol (−)-Epicatechin Prevents Stroke Damage through the Nrf2/HO1 Pathway
  53. Neurovascular protection by post‐ischemic intravenous injections of the lipoxin A 4 receptor agonist, BML ‐111, in a rat model of ischemic stroke
  54. Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury
  55. Oral administration of the flavanol (−)-epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway
  56. Cathepsin G-Dependent Modulation of Platelet Thrombus Formation In Vivo by Blood Neutrophils
  57. Role of PGE2 EP1 Receptor in Intracerebral Hemorrhage-Induced Brain Injury
  58. Neuroprotective Properties and Mechanisms of Resveratrol in in Vitro and in Vivo Experimental Cerebral Stroke Models
  59. PGE2 EP1 Receptor Deletion Attenuates 6-OHDA-Induced Parkinsonism in Mice: Old Switch, New Target
  60. Contribution of PGE2 EP1 receptor in hemin-induced neurotoxicity
  61. Effect of temperature on CO sensing response in air ambient by using ZnO nanorod-gated AlGaN/GaN high electron mobility transistors
  62. Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity
  63. PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease
  64. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage
  65. Putative Role of Prostaglandin Receptor in Intracerebral Hemorrhage
  66. Carbon monoxide detection sensitivity of ZnO nanorod-gated AlGaN/GaN high electron mobility transistors in different temperature environments
  67. Translating Basic Science Research to Clinical Application: Models and Strategies for Intracerebral Hemorrhage
  68. Effect of temperature on CO detection sensitivity of ZnO nanorod-gated AlGaN/GaN high electron mobility transistors
  69. Carbon Monoxide–Activated Nrf2 Pathway Leads to Protection Against Permanent Focal Cerebral Ischemia
  70. Dietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins
  71. Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection
  72. Fenoldopam Preconditioning: Role of Heme Oxygenase-1 in Protecting Human Tubular Cells and Rodent Kidneys Against Cold-Hypoxic Injury
  73. Myelin-associated glycoprotein protects neurons from excitotoxicity
  74. Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia
  75. Cytosolic phospholipase A2alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice
  76. The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke
  77. Resveratrol protects against experimental stroke: Putative neuroprotective role of heme oxygenase 1
  78. Microsomal prostaglandin E synthase-2: Cellular distribution and expression in Alzheimer's disease
  79. The flavanol (−)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway
  80. Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice
  81. Neuroprotective effect of HT008-1, a prescription of traditional Korean medicine, on transient focal cerebral ischemia model in rats
  82. Serine Racemase Deletion Protects Against Cerebral Ischemia and Excitotoxicity
  83. Death-Associated Protein Kinase-Mediated Cell Death Modulated by Interaction with DANGER
  84. Importance of normothermia control in investigating delayed neuronal injury in a mouse global ischemia model
  85. GOSPEL: A Neuroprotective Protein that Binds to GAPDH upon S-Nitrosylation
  86. Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia
  87. Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia
  88. Heme–Hemopexin Complex Attenuates Neuronal Cell Death and Stroke Damage
  89. Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia
  90. Low Doses of Carbon Monoxide Protect Against Experimental Focal Brain Ischemia
  91. PGF2α FP Receptor Contributes to Brain Damage Following Transient Focal Brain Ischemia
  92. Ginkgo Biloba Extract Neuroprotective Action Is Dependent on Heme Oxygenase 1 in Ischemic Reperfusion Brain Injury
  93. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation
  94. Cytosolic Prostaglandin E Synthase: Expression Patterns in Control and Alzheimer's Disease Brains
  95. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: A randomized, double-blind, placebo-controlled, trial
  96. Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse
  97. Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage
  98. Role of heme oxygenase-2 in pial arteriolar response to acetylcholine in mice with and without transfusion of cell-free hemoglobin polymers
  99. The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood
  100. Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls
  101. Neuroprotection and Enhancement of Spatial Memory by Herbal Mixture HT008-1 in Rat Global Brain Ischemia Model
  102. Elevated microsomal prostaglandin‐E synthase‐1 in Alzheimer's disease
  103. Optimized protocol to reduce variable outcomes for the bilateral common carotid artery occlusion model in mice
  104. Role of Nrf2 in protection against intracerebral hemorrhage injury in mice
  105. PGD2 DP1 receptor protects brain from ischemia-reperfusion injury
  106. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury
  107. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage
  108. Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury
  109. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice
  110. Stimulation of Prostaglandin EP2 Receptors Prevents NMDA-Induced Excitotoxicity
  111. Inflammation after Intracerebral Hemorrhage
  112. GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE2 EP1 receptor
  113. Use of an Optimized Transient Occlusion of the Middle Cerebral Artery Protocol for the Mouse Stroke Model
  114. Erratum to “Prostaglandin EP4 receptor agonist protects against acute neurotoxicity” [Brain Res. 1066 (2005) 71–77]
  115. Heme oxygenase 2 is neuroprotective against intracerebral hemorrhage
  116. Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin
  117. 1-HydroxyPGE1reduces infarction volume in mouse transient cerebral ischemia
  118. Heme oxygenase-1 protects brain from acute excitotoxicity
  119. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity
  120. Stimulation of PGE2receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure
  121. Prostaglandin EP1 Receptor Contributes to Excitotoxicity and Focal Ischemic Brain Damage
  122. Expression of Prostaglandin E2 Synthases in Mouse Postnatal Cortical Neurons
  123. Catalytically inactive heme oxygenase-2 mutant is cytoprotective
  124. Questions and Answers: Session II: Mechanisms of Neuroprotection (1)
  125. Questions and Answers: Session IV: Role of Carnitines and Other Agents in Neuroprotection
  126. Questions and Answers: Session X: Novel Approaches to Neuroprotection
  127. Characterization of Heme Oxygenase in Adult Rodent Platelets
  128. Stroke Outcomes in Mice Lacking the Genes for Neuronal Heme Oxygenase-2 and Nitric Oxide Synthase
  129. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity
  130. Unique Properties of Polyphenol Stilbenes in the Brain: More than Direct Antioxidant Actions; Gene/Protein Regulatory Activity
  131. Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia
  132. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction
  133. Regulation of Heme Oxygenase Expression by Cyclopentenone Prostaglandins
  134. Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and in Alzheimer’s disease1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Str...
  135. Corrigendum to “Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long–Evans rats”
  136. Physiologic roles for the heme oxygenase products carbon monoxide, bilirubin and iron: links to neuroprotection in stroke and Alzheimer's disease
  137. Amyloid Precursor Proteins Inhibit Heme Oxygenase Activity and Augment Neurotoxicity in Alzheimer's Disease
  138. Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long–Evans rats
  139. Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia
  140. The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid
  141. Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke
  142. Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke
  143. Neuroprotective Action of Bilirubin against Oxidative Stress in Primary Hippocampal Cultures
  144. Protective and Rescuing Abilities of IGF-I and Some Putative Free Radical Scavengers against beta-Amyloid-Inducing Toxicity in Neurons
  145. Impact of neonatal kainate treatment on hippocampal insulin-like growth factor receptors
  146. Haem oxygenase-1 prevents cell death by regulating cellular iron
  147. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury
  148. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation
  149. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats
  150. Discussion
  151. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation
  152. Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity
  153. Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons
  154. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients
  155. Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I
  156. Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients
  157. Increased insulin-like growth factor 1 production by human osteoarthritic chondrocytes is not dependent on growth hormone action
  158. Effects of exercise during normoxia and hypoxia on the growth hormone?insulin-like growth factor I axis
  159. Human Osteoarthritic Chondrocytes Possess an Increased Number of Insulin-Like Growth Factor 1 Binding Sites but are Unresponsive to its Stimulation
  160. Contribution of hGH20K variant to blood hGH response in sauna and exercise